Hilltelligence markHilltelligence
Archived This bill is from the 117th Congress (2021–2022) and is no longer under active consideration.
Bills/S. 4152117th Congress

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Senate: Referred
Companion bill: H.R. 7658(Identical bill)
Cosponsors
2
Introduced
2022-05-05
Last action
2022-05-05

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. SenateLatest

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. Senate

    Introduced in Senate

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.